We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+3.29%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$43.8B
AUM Growth
+$2.95B
Cap. Flow
+$2.92B
Cap. Flow %
6.68%
Top 10 Hldgs %
29.71%
Holding
2,321
New
255
Increased
1,689
Reduced
325
Closed
50

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$408M
2
NVDA icon
NVIDIA
NVDA
+$395M
3
MSFT icon
Microsoft
MSFT
+$382M
4
AMZN icon
Amazon
AMZN
+$253M
5
PLTR icon
Palantir
PLTR
+$148M

Sector Composition

Rank Sector Weight
1 Technology 32.42%
2 Consumer Discretionary 10.78%
3 Consumer Staples 10.15%
4 Industrials 10.05%
5 Financials 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LAUR icon
1101
Laureate Education
LAUR
$5.18B
$671K ﹤0.01%
36,687
+11,341
+45% +$199K
AVTR icon
1102
Avantor
AVTR
$7.81B
$671K ﹤0.01%
31,843
+2,197
+7% +$49.4K
VIAV icon
1103
Viavi Solutions
VIAV
$9.75B
$671K ﹤0.01%
66,390
+20,419
+44% +$202K
EVTC icon
1104
Evertec
EVTC
$1.83B
$670K ﹤0.01%
19,408
+5,964
+44% +$205K
ACM icon
1105
Aecom
ACM
$9.07B
$670K ﹤0.01%
6,272
+427
+7% +$46.6K
DRS icon
1106
Leonardo DRS
DRS
$12.8B
$670K ﹤0.01%
20,733
+6,822
+49% +$222K
WERN icon
1107
Werner Enterprises
WERN
$2.54B
$668K ﹤0.01%
18,592
+5,720
+44% +$219K
EWTX icon
1108
Edgewise Therapeutics
EWTX
$4.39B
$666K ﹤0.01%
24,928
+5,669
+29% +$181K
ZUO
1109
DELISTED
Zuora, Inc.
ZUO
$665K ﹤0.01%
67,030
+12,058
+22% +$117K
CURB
1110
Curbline Properties
CURB
$3.6B
$665K ﹤0.01%
+28,619
New +$673K
AMR icon
1111
Alpha Metallurgical Resources
AMR
$1.82B
$663K ﹤0.01%
3,312
+1,019
+44% +$228K
ARCB icon
1112
ArcBest
ARCB
$3.44B
$662K ﹤0.01%
7,092
+2,177
+44% +$230K
DYN icon
1113
Dyne Therapeutics
DYN
$4.04B
$661K ﹤0.01%
28,044
+6,862
+32% +$203K
ADUS icon
1114
Addus HomeCare
ADUS
$2.14B
$660K ﹤0.01%
5,263
+1,619
+44% +$205K
INFN
1115
DELISTED
Infinera Corporation Common Stock
INFN
$658K ﹤0.01%
100,210
+22,685
+29% +$151K
LGND icon
1116
Ligand Pharmaceuticals
LGND
$6.02B
$658K ﹤0.01%
6,144
+1,490
+32% +$168K
WAFD icon
1117
WaFd
WAFD
$2.72B
$658K ﹤0.01%
20,413
-8,023
-28% -$282K
IVT icon
1118
InvenTrust Properties
IVT
$2.84B
$658K ﹤0.01%
21,831
+8,954
+70% +$269K
MRCY icon
1119
Mercury Systems
MRCY
$6.2B
$657K ﹤0.01%
15,647
+4,294
+38% +$164K
CLSK icon
1120
CleanSpark
CLSK
$3.73B
$656K ﹤0.01%
71,198
+27,125
+62% +$328K
CON
1121
Concentra Group Holdings
CON
$4.04B
$656K ﹤0.01%
+33,141
New +$685K
KYMR icon
1122
Kymera Therapeutics
KYMR
$9.1B
$655K ﹤0.01%
16,293
+4,071
+33% +$184K
VERA icon
1123
Vera Therapeutics
VERA
$2.54B
$655K ﹤0.01%
15,487
+4,883
+46% +$216K
AMTM
1124
Amentum Holdings
AMTM
$5.51B
$653K ﹤0.01%
31,054
+13,932
+81% +$360K
EXTR icon
1125
Extreme Networks
EXTR
$3.86B
$652K ﹤0.01%
38,924
+12,622
+48% +$204K

Similar funds

ProShare Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, ProShare Advisors held 2,321 positions worth $43.8B, up 7.2% from $40.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

ProShare Advisors deployed $2.92B of net new capital in Q4 2024, opening 255 new positions and adding to 1,689 existing holdings. Its largest new stake was Applovin: 338,942 shares worth $110M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Walmart Inc, an estimated $285M trimmed.

  • ProShare Advisors's largest Q4 2024 buy was Applovin: 338,942 shares worth $110M.
  • ProShare Advisors added most to Apple in Q4 2024, an estimated $408M increase.
  • ProShare Advisors's biggest Q4 2024 reduction was Walmart Inc, cutting an estimated $285M.
  • ProShare Advisors fully exited PetIQ, Inc. Class A Common Stock in Q4 2024, selling an estimated $3.25M.
  • ProShare Advisors's ten largest holdings make up 30% of its $43.8B portfolio in Q4 2024.
  • ProShare Advisors opened 255 new positions and closed 50 in Q4 2024.
  • ProShare Advisors's portfolio value rose 7.2% quarter-over-quarter to $43.8B.

Based on ProShare Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.